IMA (STOCKS)
ImageneBio, Inc. Common Stock
$5.870000
-0.120000 (-2.00%)
Prev close: $5.990000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kristin Yarema
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $69.92M
- Employees
- 15
- P/E (TTM)
- -1.15
- P/B (TTM)
- 0.48
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
2
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.63 | $-0.90 | +0.2740 | +30.31% |
|
Mar 2026 (Q1)
|
$-0.95 | $-0.71 | -0.2395 | -33.71% |
|
Dec 2025 (Q4)
|
$-1.42 | $-1.46 | +0.0411 | +2.81% |
|
Sep 2025 (Q3)
|
$-2.91 | $-1.29 | -1.6172 | -125.09% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $6.15M |
| Operating Expenses | $58.96M |
| Depreciation and Amortization | $395.00K |
| Research and Development | $31.46M |
| Other Operating Expenses | $27.11M |
| Operating Income/Loss | -$58.96M |
| Income/Loss From Continuing Operations After Tax | -$52.48M |
| Income/Loss From Continuing Operations Before Tax | -$52.81M |
| Income Tax Expense/Benefit | -$324.00K |
| Net Income/Loss | -$52.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$52.48M |
| Net Income/Loss Available To Common Stockholders, Basic | -$53.33M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $846.00K |
| Preferred Stock Dividends And Other Adjustments | $846.00K |
| Basic Earnings Per Share | -$4.09 |
| Diluted Earnings Per Share | -$4.09 |
| Assets | $152.05M |
| Current Assets | $141.11M |
| Cash | $136.20M |
| Other Current Assets | $4.91M |
| Noncurrent Assets | $10.93M |
| Liabilities | $9.97M |
| Current Liabilities | $6.57M |
| Accounts Payable | $977.00K |
| Wages | $2.25M |
| Other Current Liabilities | $3.34M |
| Noncurrent Liabilities | $3.40M |
| Equity | $142.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $142.07M |
| Liabilities And Equity | $152.05M |
| Net Cash Flow From Operating Activities | -$52.59M |
| Net Cash Flow From Operating Activities, Continuing | -$52.59M |
| Net Cash Flow From Investing Activities | -$39.48M |
| Net Cash Flow From Investing Activities, Continuing | -$12.69M |
| Net Cash Flow From Financing Activities | $147.23M |
| Net Cash Flow From Financing Activities, Continuing | $147.23M |
| Exchange Gains/Losses | $614.00K |
| Net Cash Flow | $82.55M |
| Net Cash Flow, Continuing | $81.94M |
| Comprehensive Income/Loss | -$52.54M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$52.54M |
| Other Comprehensive Income/Loss | -$24.83M |